While still in its prototype phase, the Tensegrity foot is designed to mimic the action of a jointed foot to allow for a more natural and stable gait. Built by inventor and mechanical engineer Jerome Rifkin, the artificial foot bends like a normal foot and ankle, and conforms to the terrain underneath it.

ARLINGTON, Va., June 16 /PRNewswire-USNewswire/ — The American Association for Homecare (AAHomecare) applauded Congressional efforts to pass a bill introduced last week that will delay for at least 18 months the controversial and flawed Medicare competitive bidding program for home medical equipment and services. The bill, H.R. 6252, is titled the “Medicare DMEPOS Competitive Acquisition Reform Act of 2008.”

The competitive acquisition or “competitive bidding” program for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) is
scheduled to begin on July 1, 2008 in ten metropolitan areas: Charlotte, NC; Cincinnati, Ohio; Cleveland, Ohio; Dallas - Ft. Worth, Texas; Miami,
Fla.; Orlando, Fla.; Pittsburgh, Pa.; Riverside, Calif.; and San Juan, P.R. The bidding program applies to oxygen therapy, mail-order diabetic
supplies, power wheelchairs, CPAP equipment, hospital beds, and several other categories of durable medical equipment and services used by Medicare beneficiaries in their homes. The program is scheduled to expand to 70 additional areas in the U.S. in 2009.

The reform bill, H.R. 6252, would delay the program for at least 18 months in order to improve the program. The lead cosponsors are House Ways and Means Committee health subcommittee chair Pete Stark (D-Calif.) and subcommittee ranking member David Camp (R-Mich.). View the text at http://www.aahomecare.org.

According to a press release issued by Congressmen Stark and Camp, the bill would require the federal Centers for Medicare and Medicaid Services (CMS) to “improve the program for both beneficiaries and suppliers. The cost of the delay and accompanying reforms is fully paid for within the DME sector by reducing payment rates for covered items by 9.5 percent nationwide starting in 2009, but provides for an additional increase of 2 percent in 2014.”

Congressman Stark stated in the release, “I’m pleased to introduce this bipartisan bill and look forward to working with my colleagues for its
swift passage so that the program can be redesigned to meet the needs of patients, providers and taxpayers.” He added, “This is no free lunch. This bill requires the DME industry to finance the cost of delaying the program.”

In the same press release, Congressman Camp states, “The implementation of this necessary program has been flawed and needed to be fixed. This bill provides us with the time to get the program right and ensure we are reducing costs while protecting beneficiaries in the long run.”

In addition to Stark and Camp, other cosponsors of the bill include Ways and Means Chair Charles Rangel (D-N.Y.), Republican Minority Leader
John Boehner (R-Ohio), Energy and Commerce Committee Chair John Dingell (D-Mich.), Energy and Commerce subcommittee chair Frank Pallone (D-N.J.) and two dozen other Representatives.

American Association for Homecare President Tyler J. Wilson added, “We are grateful for the leadership of Congressmen Stark and Camp on this issue of immense importance to the homecare community. This bill is critical to making important improvements to Medicare policy that will protect
America’s seniors and people with disabilities who depend on home medical equipment and services in their homes. If allowed to go forward, the
bidding program will put thousands of qualified homecare providers out of business and reduce patients’ access to quality home medical equipment and services. Homecare is cost-effective and represents the smallest and slowest-growing sector of Medicare. We applaud efforts to preserve quality care in the home.”

Organizations supporting H.R. 6252 were listed in the press release issued by Congressmen Stark and Camp. They include:

— American Academy of Physical Medicine and Rehabilitation
— American Association for Homecare
— American Podiatric Medical Association
— American Society of Transplantation
— Consortium for Citizens with Disabilities Health Task Force
— Health Industry Distributors of America
— Independence Through Enhancement of Medicare and Medicaid (ITEM) Coalition
— National Coalition for Assistive and Rehab Technology
— National Community Pharmacists Association
— Orthotic and Prosthetic Alliance
— Pedorthic Footwear Association
— The Endocrine Society
— Vision Council of America
— Wound Ostomy Continence Nurses Society

Contacts: Michael Reinemer, 703-535-1881; michaelr@aahomecare.org; Tilly Gambill, 703-535-1896; tillyg@aahomecare.org

The American Association for Homecare represents providers, equipment manufacturers, and other organizations in the homecare community. Members serve the medical needs of millions of Americans who require oxygen equipment and therapy, mobility assistive technologies, medical supplies, inhalation drug therapy, home infusion, and other medical equipment and services in their homes. Membership includes providers of all sizes operating approximately 3,000 locations in all 50 states. See http://www.aahomecare.org.

Scientists at the Keio University in Japan used a commercially available EEG headband to allow a human to control a character walking around the Second Life virtual world, all through raw brain power. Obviously this technology has tremendous potential for disabled individuals, and may also become a new type of joystick for controlling machinery and video games of the future.

A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.

“We didn’t expect such a dramatic return of function,” says Douglas Kerr, M.D., Ph.D, associate professor of neurology at the Johns Hopkins University School of Medicine. “Although we’re very early in the game, we think this approach could be the linchpin of a significant advance for MS treatment.”

Researchers have used the so called HiCy treatments with some success at Johns Hopkins for a variety of other immune system disorders, including aplastic anemia, lupus and myasthenia gravis.

Cyclophosphamide kills immune-system cells but spares the bone marrow stem cells that make them. The usual method of delivering it in pulsed, small doses, however, can cause the drug to build up to toxic concentrations in patients’ bodies, causing a variety of side effects, including a greatly increased risk of infection.

Seeking an alternative way to use the drug, Kerr and his colleagues reasoned that HiCy might clear out the majority of a patient’s immune system in one fell swoop, then allow it to ‘reboot,’ giving nerve cells a fresh start and an opportunity to repair themselves. In the current study, nine MS patients got a total single infusion of 200 milligrams per kilogram of cyclophosphamide intravenously over four days, a dose several times higher than that given in pulsed regimens but significantly lower than the total amount usually given patients over time.

Before treatment, Kerr says, the study participants were “the worst of the worst” among MS patients. Eight of the nine patients had failed conventional MS treatments, and several of them were wheelchair-bound.

President Bush has asked Congress for sweeping changes to the Americans With Disabilities Act (ADA) designed to improve educational, employment and social opportunities for over 54 million disabled Americans.

Signed into law eleven years ago by President George Bush, the ADA represented the first major piece of civil rights legislation since the Civil Rights Act of 1964 and opened many of the real and virtual doors of society closed for years to the disabled.

“Because of that law, millions of Americans can now compete for jobs once denied them; enter buildings once closed to them; travel on buses and trains once unequipped for them,” stated President Bush in a Feb. 1, 2001 announcement.

# Lower cost and improve access to “assistive” technologies (text telephones, adaptive computer equipment, lightweight and powered wheelchairs, modern artificial limbs, etc.)
# Expand employment opportunities for the disabled, including opportunities for the disabled to work from home.
# Offer new transportation solutions for the disabled.
# Improve access to places of worship.

Boston, MA-Scientists at Schepens Eye Research Institute have identified specific molecules in the brain that are responsible for awakening and putting to sleep brain stem cells, which, when activated, can transform into neurons (nerve cells) and repair damaged brain tissue. Their findings are published online this week in the Proceedings of the National Academy of Science (PNAS).

An earlier paper (published in the May issue of Stem Cells) by the same scientists laid the foundation for the PNAS study findings by demonstrating that neural stem cells exist in every part of the brain, but are mostly kept silent by chemical signals from support cells known as astrocytes.

³The findings from both papers should have a far-reaching impact,² says principal investigator, Dr. Dong Feng Chen, who is an associate scientist at Schepens Eye Research Institute and an assistant professor of ophthalmology at Harvard Medical School. Chen believes that tapping the brain¹s dormant, but intrinsic, ability to regenerate itself is the best hope for people suffering from brain-ravaging diseases such as Parkinson¹s or Alzheimer¹s disease or traumatic brain or spinal cord injuries.

A new report shows that a non-ambulatory (unable to walk or stand) child with a cervical spinal cord injury was able to restore basic walking function after intensive locomotor training. The case study, published in Physical Therapy (May 2008), the scientific journal of the American Physical Therapy Association (APTA), evaluated the effects of locomotor training in a 4 ½ year-old-boy, who had no ability to walk following a gunshot wound sixteen months earlier.

Newswise — Movies portray robots that can move through the world as easily as humans, and use their hands to operate everything from dishwashers to computers with ease. But in reality, the creation of robots with these skills remains a major challenge. Researchers at the University of Massachusetts Amherst are solving this problem by giving a mobile robotic arm the ability to “see” its environment through a digital camera.

“Mobile robots play an important role in many settings, including planetary exploration and manufacturing,” says Dov Katz, a doctoral student of computer science. “Giving them the ability to manipulate objects will extend their use in medical care and household assistance.”

Results of experiments performed by Katz and Oliver Brock, a professor of computer science, were presented at the Proceedings of the International Electrical and Electronics Engineers Conference on Robotics and Automation May 21 in Pasadena, Calif.

So far, the team has successfully taught their creation, dubbed the UMan, or UMass Mobile Manipulator, to approach unfamiliar objects, such as scissors, garden shears and jointed wooden toys – and learn how they work by pushing on them and observing how they change, the same process used by children as they explore the world.

A new study from the University of Alabama at Birmingham indicates that the OtisKnee Custom Fit Knee™ Replacement system may have a positive impact on length of hospital stay, range of motion, pain level and patient satisfaction immediately following total knee replacement surgery. The study abstract, titled “MRI-Guided Custom-Fit Total Knee Replacement: The First Six Weeks,” was presented at the joint Alabama Orthopedic Society and Mississippi Orthopedic Society annual meeting on May 3, 2008 in Sandestin, Fla. by Herrick Siegel, M.D., associate professor of surgery at the University of Alabama at Birmingham and lead investigator of the study.